糖尿病黄斑浮腫治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR1834)
◆英語タイトル:Global Diabetic Macular Edema Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR1834
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:94
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、糖尿病黄斑浮腫治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(レーザー光凝固療法、薬物療法、ベバシズマブ、ラニビズマブ、トリアムシノロン)、用途別市場規模(病院、眼科クリニック、研究所、委託研究機関)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・糖尿病黄斑浮腫治療の市場動向
・企業の競争状況、市場シェア
・糖尿病黄斑浮腫治療の種類別市場規模(レーザー光凝固療法、薬物療法、ベバシズマブ、ラニビズマブ、トリアムシノロン)
・糖尿病黄斑浮腫治療の用途別市場規模(病院、眼科クリニック、研究所、委託研究機関)
・糖尿病黄斑浮腫治療の北米市場規模2016-2027(アメリカ、カナダ)
・糖尿病黄斑浮腫治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・糖尿病黄斑浮腫治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・糖尿病黄斑浮腫治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・糖尿病黄斑浮腫治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Genentech、Novartis、GlaxoSmithKline、Eyetech Pharmaceuticals、Alimera Sciences)
・結論
【レポートの概要】

Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.
Increasing prevalence of diabetes in the prime factor driving growth of global diabetic macular edema therapeutics market. The prevalence of diabetic macular edema is higher in type 2 diabetes patients than in type 1 diabetes patients. As per study conducted by University Hospital Sant Joan de Reus Spain, the incidence of diabetic macular edema is in the range of 0.9%-2.3%, annually, across the globe. Besides this, substantial R&D investment by pharmaceutical companies and advancement in ophthalmic surgrey techniques are some other factors fueling the growth of global diabetic macular edema treatment market.

Market Analysis and Insights: Global Diabetic Macular Edema Treatment Market
The global Diabetic Macular Edema Treatment market size is projected to reach US$ 3259.5 million by 2026, from US$ 3009.3 million in 2019, at a CAGR of 1.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Macular Edema Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Macular Edema Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Macular Edema Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Macular Edema Treatment market.

Global Diabetic Macular Edema Treatment Scope and Market Size
Diabetic Macular Edema Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Macular Edema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Laser Photocoagulation Therapy
Pharmacological Therapy
Bevacizumab
Ranibizumab
Triamcinolone

Segment by Application
Hospitals
Ophthalmic Clinics
Research Institutes
Contract Research Organizations

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Genentech
Novartis
GlaxoSmithKline
Eyetech Pharmaceuticals
Alimera Sciences

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Macular Edema Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Laser Photocoagulation Therapy
1.2.3 Pharmacological Therapy
1.2.4 Bevacizumab
1.2.5 Ranibizumab
1.2.6 Triamcinolone
1.3 Market by Application
1.3.1 Global Diabetic Macular Edema Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ophthalmic Clinics
1.3.4 Research Institutes
1.3.5 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetic Macular Edema Treatment Market Perspective (2016-2027)
2.2 Diabetic Macular Edema Treatment Growth Trends by Regions
2.2.1 Diabetic Macular Edema Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Macular Edema Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Macular Edema Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Macular Edema Treatment Industry Dynamic
2.3.1 Diabetic Macular Edema Treatment Market Trends
2.3.2 Diabetic Macular Edema Treatment Market Drivers
2.3.3 Diabetic Macular Edema Treatment Market Challenges
2.3.4 Diabetic Macular Edema Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetic Macular Edema Treatment Players by Revenue
3.1.1 Global Top Diabetic Macular Edema Treatment Players by Revenue (2016-2021)
3.1.2 Global Diabetic Macular Edema Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Macular Edema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Macular Edema Treatment Revenue
3.4 Global Diabetic Macular Edema Treatment Market Concentration Ratio
3.4.1 Global Diabetic Macular Edema Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Macular Edema Treatment Revenue in 2020
3.5 Diabetic Macular Edema Treatment Key Players Head office and Area Served
3.6 Key Players Diabetic Macular Edema Treatment Product Solution and Service
3.7 Date of Enter into Diabetic Macular Edema Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Macular Edema Treatment Breakdown Data by Type
4.1 Global Diabetic Macular Edema Treatment Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Macular Edema Treatment Forecasted Market Size by Type (2022-2027)

5 Diabetic Macular Edema Treatment Breakdown Data by Application
5.1 Global Diabetic Macular Edema Treatment Historic Market Size by Application (2016-2021)
5.2 Global Diabetic Macular Edema Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diabetic Macular Edema Treatment Market Size (2016-2027)
6.2 North America Diabetic Macular Edema Treatment Market Size by Type
6.2.1 North America Diabetic Macular Edema Treatment Market Size by Type (2016-2021)
6.2.2 North America Diabetic Macular Edema Treatment Market Size by Type (2022-2027)
6.2.3 North America Diabetic Macular Edema Treatment Market Size by Type (2016-2027)
6.3 North America Diabetic Macular Edema Treatment Market Size by Application
6.3.1 North America Diabetic Macular Edema Treatment Market Size by Application (2016-2021)
6.3.2 North America Diabetic Macular Edema Treatment Market Size by Application (2022-2027)
6.3.3 North America Diabetic Macular Edema Treatment Market Size by Application (2016-2027)
6.4 North America Diabetic Macular Edema Treatment Market Size by Country
6.4.1 North America Diabetic Macular Edema Treatment Market Size by Country (2016-2021)
6.4.2 North America Diabetic Macular Edema Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Diabetic Macular Edema Treatment Market Size (2016-2027)
7.2 Europe Diabetic Macular Edema Treatment Market Size by Type
7.2.1 Europe Diabetic Macular Edema Treatment Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Macular Edema Treatment Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Macular Edema Treatment Market Size by Type (2016-2027)
7.3 Europe Diabetic Macular Edema Treatment Market Size by Application
7.3.1 Europe Diabetic Macular Edema Treatment Market Size by Application (2016-2021)
7.3.2 Europe Diabetic Macular Edema Treatment Market Size by Application (2022-2027)
7.3.3 Europe Diabetic Macular Edema Treatment Market Size by Application (2016-2027)
7.4 Europe Diabetic Macular Edema Treatment Market Size by Country
7.4.1 Europe Diabetic Macular Edema Treatment Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Macular Edema Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diabetic Macular Edema Treatment Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Type
8.2.1 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Application
8.3.1 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Region
8.4.1 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diabetic Macular Edema Treatment Market Size (2016-2027)
9.2 Latin America Diabetic Macular Edema Treatment Market Size by Type
9.2.1 Latin America Diabetic Macular Edema Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Macular Edema Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Macular Edema Treatment Market Size by Type (2016-2027)
9.3 Latin America Diabetic Macular Edema Treatment Market Size by Application
9.3.1 Latin America Diabetic Macular Edema Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Diabetic Macular Edema Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Diabetic Macular Edema Treatment Market Size by Application (2016-2027)
9.4 Latin America Diabetic Macular Edema Treatment Market Size by Country
9.4.1 Latin America Diabetic Macular Edema Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Macular Edema Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diabetic Macular Edema Treatment Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Type
10.2.1 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Application
10.3.1 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Country
10.4.1 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Genentech
11.1.1 Genentech Company Details
11.1.2 Genentech Business Overview
11.1.3 Genentech Diabetic Macular Edema Treatment Introduction
11.1.4 Genentech Revenue in Diabetic Macular Edema Treatment Business (2016-2021)
11.1.5 Genentech Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Diabetic Macular Edema Treatment Introduction
11.2.4 Novartis Revenue in Diabetic Macular Edema Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Diabetic Macular Edema Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Diabetic Macular Edema Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Eyetech Pharmaceuticals
11.4.1 Eyetech Pharmaceuticals Company Details
11.4.2 Eyetech Pharmaceuticals Business Overview
11.4.3 Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Introduction
11.4.4 Eyetech Pharmaceuticals Revenue in Diabetic Macular Edema Treatment Business (2016-2021)
11.4.5 Eyetech Pharmaceuticals Recent Development
11.5 Alimera Sciences
11.5.1 Alimera Sciences Company Details
11.5.2 Alimera Sciences Business Overview
11.5.3 Alimera Sciences Diabetic Macular Edema Treatment Introduction
11.5.4 Alimera Sciences Revenue in Diabetic Macular Edema Treatment Business (2016-2021)
11.5.5 Alimera Sciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 糖尿病黄斑浮腫治療の世界市場規模・現状・予測2021年-2027年(Global Diabetic Macular Edema Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。